Thrombolysis in Pulmonary Embolism
Thrombolytic therapy is indicated for patients with massive pulmonary embolism (PE) presenting with shock and/or hypotension, and should be administered as 100 mg of alteplase over 2 hours intravenously. 1, 2, 3
Definition and Classification of PE
- Massive PE: Defined as PE with shock and/or hypotension (systolic blood pressure <90 mmHg for at least 15 minutes or requiring inotropic support) 1, 3
- Submassive PE: Defined as PE with evidence of right ventricular (RV) dysfunction without hypotension 1
Treatment Algorithm for Massive PE
First-line therapy: Administer alteplase 100 mg over 2 hours via peripheral intravenous catheter 1, 2, 3
Anticoagulation management:
If thrombolysis fails:
Treatment Considerations for Submassive PE
- Thrombolysis may be considered for patients with submassive PE who have RV dysfunction on echocardiography, elevated cardiac biomarkers (troponin, BNP), and no contraindications to fibrinolysis 1, 5
- The benefit of thrombolysis in submassive PE is less clear than in massive PE, but it can prevent clinical deterioration requiring escalation of treatment 5
Contraindications to Thrombolysis
- Absolute contraindications: Recent hemorrhage, stroke, current gastrointestinal hemorrhage 1
- Relative contraindications: Peptic ulcer disease, surgery within preceding seven days, prolonged cardiorespiratory resuscitation 1
- Most contraindications are considered relative in the setting of life-threatening massive PE 1, 3
Diagnostic Confirmation Before Thrombolysis
- It is preferable to confirm PE diagnosis with imaging (CTPA, V/Q scan) before initiating thrombolysis 1, 3
- When imaging is unavailable or unsafe due to patient instability, thrombolysis may be considered based on high clinical suspicion and evidence of RV dysfunction on bedside echocardiography 1, 2
Monitoring and Outcomes
- Monitor for clinical improvement and hemodynamic parameters (pulmonary artery pressure, cardiac index) 3, 6
- Expect improvement in hemodynamic parameters within 1-2 hours after thrombolysis 6, 7
- Major bleeding occurs in approximately 11-24% of patients depending on the regimen 3, 7
Special Considerations
- In pregnancy, thrombolysis may be appropriate for massive PE but should be avoided within six hours of delivery or in the early postpartum period due to high bleeding risk 1
- Consider inferior vena caval (IVC) filters for patients at high risk of further emboli in whom anticoagulation is contraindicated or in those with recurrent embolism despite adequate anticoagulation 1